Abstract
Probiotics, the friendly bugs, has gained impressive attention
worldwide due to their nutraceutical and pharmaceutical benefits,
established
in recent years. However existing regulatory regime in various countries
has ambiguities regarding its classification based on intended use and
respective approval process. Author and his coworkers have proposed a
revised definition and categorization of probiotic products along with
possible path to develop a comprehensive guideline for global enactment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.